High-signal-intensity MR Image in the Hepatobiliary Phase Predicts Long-term Survival in Patients With Hepatocellular Carcinoma.


Journal

Anticancer research
ISSN: 1791-7530
Titre abrégé: Anticancer Res
Pays: Greece
ID NLM: 8102988

Informations de publication

Date de publication:
Aug 2019
Historique:
received: 16 05 2019
revised: 17 06 2019
accepted: 19 06 2019
entrez: 2 8 2019
pubmed: 2 8 2019
medline: 8 8 2019
Statut: ppublish

Résumé

The aim of the study was to evaluate surgical outcomes of patients with high-signal intensity (SI) image hepatocellular carcinoma (HCC). Between 2008 and 2013, 257 HCC patients were retrospectively evaluated. A total of 21 patients were diagnosed as high-SI image HCC, 215 as low-SI image HCC, and 21 patients as mixed (high and low)-SI image HCC in the hepatobiliary (HB) phase of MRI. Five-year overall survival (OS) and recurrence-free survival (RFS) were compared among patient groups. The 5-year OS and RFS rates were significantly higher in patients with high-SI image HCC (100% and 56%) than in patients with low-SI image HCC (71%; p=0.097 and 38%; p=0.0209) and in patients with mixed-SI image HCC (73%; p=0.0329 and 9%; p=0.0021). High-SI image was an independent prognostic factor for OS (relative risk 0.167, p=0.0178) and RFS (relative risk 0.471, p=0.0322) on multivariate analysis. Patients with high-SI image HCC showed favorable long-term survival after curative surgery.

Sections du résumé

BACKGROUND/AIM OBJECTIVE
The aim of the study was to evaluate surgical outcomes of patients with high-signal intensity (SI) image hepatocellular carcinoma (HCC).
PATIENTS AND METHODS METHODS
Between 2008 and 2013, 257 HCC patients were retrospectively evaluated. A total of 21 patients were diagnosed as high-SI image HCC, 215 as low-SI image HCC, and 21 patients as mixed (high and low)-SI image HCC in the hepatobiliary (HB) phase of MRI. Five-year overall survival (OS) and recurrence-free survival (RFS) were compared among patient groups.
RESULTS RESULTS
The 5-year OS and RFS rates were significantly higher in patients with high-SI image HCC (100% and 56%) than in patients with low-SI image HCC (71%; p=0.097 and 38%; p=0.0209) and in patients with mixed-SI image HCC (73%; p=0.0329 and 9%; p=0.0021). High-SI image was an independent prognostic factor for OS (relative risk 0.167, p=0.0178) and RFS (relative risk 0.471, p=0.0322) on multivariate analysis.
CONCLUSION CONCLUSIONS
Patients with high-SI image HCC showed favorable long-term survival after curative surgery.

Identifiants

pubmed: 31366509
pii: 39/8/4219
doi: 10.21873/anticanres.13583
doi:

Substances chimiques

Contrast Media 0
Gadolinium DTPA K2I13DR72L

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4219-4225

Informations de copyright

Copyright© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Auteurs

Shun-Ichi Ariizumi (SI)

Department of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University, Tokyo, Japan.

Daisuke Ban (D)

Department of Hepato-Biliary-Pancreatic Surgery, Graduate School of Medicine, Tokyo Medical and Dental University, Tokyo, Japan.

Yuta Abe (Y)

Department of Surgery, School of Medicine, Keio University, Tokyo, Japan.

Takafumi Kumamoto (T)

Department of Gastroenterological Surgery, Yokohama City University, Graduate School of Medicine, Yokohama, Japan.

Satoshi Koizumi (S)

Division of Gastroenterological and General Surgery, St. Marianna University School of Medicine, Kawasaki, Japan.

Minoru Tanabe (M)

Department of Hepato-Biliary-Pancreatic Surgery, Graduate School of Medicine, Tokyo Medical and Dental University, Tokyo, Japan.

Masahiro Shinoda (M)

Department of Surgery, School of Medicine, Keio University, Tokyo, Japan.

Itaru Endo (I)

Department of Gastroenterological Surgery, Yokohama City University, Graduate School of Medicine, Yokohama, Japan.

Takehito Otsubo (T)

Division of Gastroenterological and General Surgery, St. Marianna University School of Medicine, Kawasaki, Japan.

Masakazu Yamamoto (M)

Department of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University, Tokyo, Japan yamamoto.masakazu@twmu.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH